Hair Issues

The "Cliff Effect" and Gender Disparity

Clinical data shows that the speed of your weight loss is the strongest predictor of shedding; patients losing more than 1.5% of their total body weight per week show twice the incidence of telogen effluvium — that's a temporary hair-loss condition where your hair follicles (the small sacs in your scalp that each grow a single hair) enter a resting phase too early in response to physical stress — compared to those on a more gradual path. Furthermore, research suggests that women are twice as likely as men to be diagnosed with a hair loss condition while on GLP-1 therapy, likely because female follicles are more sensitive to the rapid shifts in hormones like cortisol (your body's main stress hormone, meaning a chemical messenger that helps your body respond to stress) and leptin (a hormone that regulates hunger and energy, meaning it tells your brain how much stored energy you have) that occur during deep calorie deficits — meaning you're eating far fewer calories than your body burns. To avoid this "cliff effect," clinicians often recommend moderating your dose titration (the gradual step-up of your medication amount over time) to maintain a steady weight loss of 0.5–1% weekly, which significantly reduces the metabolic stress that triggers the shedding phase.

Advanced Interventions and Lab Cautions

For those seeking active regrowth support, topical minoxidil 5% is the only FDA-approved medication proven to stimulate hair follicles by prolonging the anagen (growth) phase of the hair cycle — meaning the part of the cycle when your hair is actively growing, as opposed to the resting phase when it sits dormant before falling out. While many users supplement with biotin (a B vitamin often marketed for hair and nail health), it is critical to understand that high doses of this vitamin can interfere with vital blood tests, including thyroid function and troponin (a protein in your blood that doctors use as a key heart-attack marker — meaning its presence can signal heart muscle damage); it must be discontinued at least 72 hours before any blood work so your results are accurate. If shedding becomes psychologically intolerable, you might discuss switching to dulaglutide with your clinician, as pharmacovigilance data (meaning the ongoing monitoring of medication side effects reported after a drug is on the market) shows it has a lower reported incidence of alopecia (the medical term for hair loss) due to its more moderate weight-loss profile compared to higher-potency agonists (meaning other GLP-1 medications that cause more aggressive weight loss).